Cryoglobulinemia future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Cryoglobulinemia}} {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} ==Overview== == Future or Investigational Therapies == * In patients with acute, severe dis..." |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 2: | Line 2: | ||
{{Cryoglobulinemia}} | {{Cryoglobulinemia}} | ||
{{CMG}}; | {{CMG}}; {{AE}} {{CZ}} | ||
==Overview== | ==Overview== | ||
| Line 13: | Line 13: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category:Blood tests]] | [[Category:Blood tests]] | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
Latest revision as of 14:56, 15 June 2016
|
Cryoglobulinemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cryoglobulinemia future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Cryoglobulinemia future or investigational therapies |
|
Cryoglobulinemia future or investigational therapies in the news |
|
Blogs on Cryoglobulinemia future or investigational therapies |
|
Risk calculators and risk factors for Cryoglobulinemia future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Future or Investigational Therapies
- In patients with acute, severe disease, plasmapheresis has been used in conjunction with high dose steroids and cytoxan.
- Uncontrolled studies demonstrated a reduction in creatinine in up to 87% of patients.